Immunology | Oncology | Pathology Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types. February 14, 2024
Oncology | Pathology Artificial intelligence-powered programmed death ligandĀ 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response. May 16, 2022